Abstract
Background: The effect of different races possess, ethnic differences, and geographical have their respective reference ranges of serum prostate-specific antigen (PSA). The distribution of serum PSA in men without prostate cancer.
Aims: We studied the importance of early detection of LUTS patients in whom prostate cancer was suspected in the transition area of prostate cancer through transurethral resections(TURP), in the case of negative transrectal ultrasound (TRUS) biopsy.
Methods: A total of 63 patients undergoing TURP were evaluated of the period from July 2019 to March 2020. TRUS biopsy patients before TURP (group with cancer) and not (without cancer) were compared to the prostate detection rates. All charts, including prostate-specified antigen (PSA), digital rectal exam (DRE) results, TURP (including volume of resection and a pathology report), TRUS and TRUS biopsy results, were evaluated retrospectively. Ethnicity has not been recorded since Al-Najaf is multi-ethnic. Description statistics, statistic tables, the arithmetic medium, standard error, default and two extremes used to analyze the results.
Results: PSA values in different age groups were non significant difference in cancer detection rate between with and without biopsy groups, the PSA mean was 4.7±1.6 ng / ml and 3.4±0.8 ng / ml, and also IPSS was 10.8± 1.4 and 9.1 ± 2.65 and p>0.05and while APEL(%) maen was 5.65±2.5 ng / ml and 10.5±1.35 ng / ml that significant difference between with and without biopsy groups and p<0.05., The detection rate for prostate cancer and PSA (p<0.05) have been positively correlated.
Conclusion : The results of serum PSA must be standardized by country and ethnic group. Ultimately, the diagnosis of prostatic carcinoma in a particular region will increase accuracy
References
Puppo P, Introini C, Calvi P, Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006;49:873-8.
Deeparani et al. In-vitro anticancer study of Vitis viniferae, Ixora coccinea and Piper longum extract on Human breast carcinoma cells. Research J.Pharm. and Tech 2018; 11(12):5345-5347.
Deeparani KU et al. Pharmacological and anticarcinogenic effects of Grape seed Extract: A comprehensive review. J of Pharmacy Research 2017, 11(6), 586-593.
Kim HG, Lee BK, Paick SH, Lho YS. Efficacy of bipolar transurethral resection of the prostate: comparison with standard monopolar transurethral resection of the prostate. Korean J Urol 2006; 47:377-80.
Kitamura H, Masumori N, Tanuma Y, Yanase M, Itoh N,Takahashi A, et al. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? Int J Urol 2002;9:95-9.
Lin KJ, Pang ST, Chang YH, Wu CT, Chuang KL, Chuang HC,et al. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer. Chang Gung Med J 2010;33:182–7.
Marwan Hailan, Usama Nihad Rifat. Age-specific reference ranges of serum prostate-specific antigen in Iraqi men. Arab Journal of Urology,05 Apr 2019.
Subrahmanyam Lanka, Vaikuntarao Lakinani, Sagar Rao Kanaparthi,Siva Rama Rao Kakani. Design and Synthesis of Novel Molecular Scaffolds of Bicaultamide derivatives for the treatment of Prostate Cell Cancer. Research J. Pharm. and Tech. 2019; 12(11): 54275432. DOI: 10.5958/0974-360X.2019.00941.7.
Lin KJ, Pang ST, Chang YH, Wu CT, Chuang KL, Chuang HC, et al. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer. Chang Gung Med J 2010;33:182–7.
Hull GW, Rabbani F, Abbas F, Wheeler TM, Ka an MW, et al. Cancer control with radical prostatectomy alone in 1000 consecutive cases. J Urol 2002; 167: 528–34.
Lin KJ, Pang ST, Chang YH, Wu CT, Chuang KL, Chuang HC, et al. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer. Chang Gung Med J 2010;33:182–7.
Kien T. Mai. Incidental Prostatic Adenocarcinomas and Putative Premalignant Lesions in TURP Specimens Collected Before and After the Introduction of Prostrate-Specific Antigen Screening Arch Pathol Lab Med—Vol 124, October 2000.
Al Sardari,1 John V. Thomas et al. Incidental Bladder Cancer Detected on Multiparametric Magnetic Resonance Imaging of the Prostate Gland, Case Reports in Urology. Volume 2015, Article ID 503154, 4 pages.
Aditi Gupta, Dharmveer Yadav et al. Establishment of Age Specific Reference Range of Serum PSA Level among Healthy Indian Hindu and Muslim Males. Biochem Anal Biochem 2015, 4:1.
Liao et al. Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH. Frontiers in Pharmacology | , April 2020 , Volume 11 page 589.
Guangxiang Liu et al. Characteristics of incidental prostate cancer after radical cystoprostatectomy for bladder carcinoma in Chinese men. Int J Clin Exp Pathol 2016;9(3):3743-3750.
Joshua B. et al. Incidental prostate cancer diagnosed at radical cystostsemy bladder cancer:disease-specific outcomes and survival. Prostste International. volume 4 (2016) 107-112.
Mathias H.et al. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cysto- prostatectomy specimens. Ju international 2007.page 99,554-558
Sayar et al. Incidental. Incidental Prostate Adenocarcinoma in Prostate Transurethral Resections: Our Eight Year Experience Journal of Urological Surgery, 2020;7(2):88-91.
Melissa M. Norström etal. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes. Oncotarget, Vol. 7, No. 17.
Cho, et al. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen. Prostate Int 2014;2(4):196-202.
U. Deeparani, S. Jayakumari. In vitro Anti-Cancer Study of Vitis viniferae, Ixora coccinea and Piper longum Extract on Human Prostate Carcinoma Cells. Research J. Pharm. and Tech 2019; 12(9):44854488.DOI: 10.5958/0974-360X.2019.00772.813.
Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ,Panser LA, et al. Serum prostate-specific antigen in a community- based population of healthy men. Establishment of agespecific reference ranges. JAMA 1993;270:860–4.
Zhi-Yong Liu et al. Age-specific PSA reference ranges in Chinese men without prostate cancer. Asian Journal of Andrology (2009) 11: 100–103.
Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84:1015-20.
Li-Bin Nan, Xiao-Tao Yin etal. Age-specific reference range of prostate-specific antigen in a population-based single-center study in the north of China. Int J Clin Exp Med 2018;11(2) : 1376- 1382
Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002;167:2435-9.
Palisaar Jüri R., Sven Wenske et al. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.Journal compilation B Juniternation 2009 . volume 104 ,611-615
Cho In-chang etal.Oncologic aspects of longterm followed incidantal prostate cancer detected by cystoprostsectomy in korain patients.prostse international,3(2019)56-51.
Hosseini S.Y., A.K. Danesh et al. Incidental Prostatic Adenocarcinoma in Patients with PSA Less than 4 ng/mL Undergoing Radical Cystoprostatectomy for Bladder Cancer in Iranian Men. International Braz J Urol Vol. 33 (2): 167-175, March - April, 2007